Partner Content Partner Content The Problem of the Hyperprolific Author When It Comes to KOL... The dangers of hyper-prolific authors
Partner Content Partner Content Mapping Human Influence Uncovering drivers of influence with qual inputs
Partner Content Partner Content Piecing Together the KOL Puzzle Creating a complete picture of your KOLs
Partner Content Partner Content Plenum Network launched to Challenge and Drive Innovation in... Plenum has launched a unique network which will support and challenge leaders in meetings and communication programmes.
News TransThera's resistant biliary cancer drug cleared in China TransThera's Yochanra has been cleared in China as the world's first drug that can overcome resistance to FGFR inhibitors in cholangiocarcinoma.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
